Notice Number: NOT-HL-13-201

Key Dates
Release Date: November 25, 2013

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

NHLBI announces Topics of Special Interest (TOSI) that are of high programmatic interest. http://www.nhlbi.nih.gov/funding/tosi/index.htm. TOSI will change periodically as Institute programmatic interests dictate. These topics are not formal announcements for applications (Funding Opportunity Announcements). Although funds are not set aside for awards on these topics, applications submitted in response to TOSI are eligible for special funding consideration. TOSI applications will be peer reviewed by standing study sections at the NIH Center for Scientific Review (CSR).

Investigators interested in developing applications for these topics are encouraged to discuss their ideas with NHLBI contacts listed below. Researchers should submit investigator-initiated R01 applications through PA-13-302.

NHLBI Topics of Special Interest TOSI:

• Development Pathways in the Pathogenesis of Adult Chronic Lung Diseases
• Advancing Research in Exercise Therapy for Chronic Heart Failure
• Phenotypic Characterization of Chronic Pain in Sickle Cell Disease

Inquiries

Please direct inquiries to:

Qing "Sara" Lin, Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Diseases (NHLBI)
Telephone: (301) 435-0222
Email: sara.lin@nih.gov

Lawton S. Cooper, M.D., M.P.H.
Division of Cardiovascular Diseases
National Heart, Lung, and Blood Diseases (NHLBI)
Telephone: 301-435-0419
Email: cooperls@nhlbi.nih.gov

Harvey Luksenburg, M.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Diseases (NHLBI)
Telephone: (301) 435-0050
Email: luksenburgh@mail.nih.gov